“Ten-Year Response to Crizotinib in ALK-Positive Inflammatory Myofibroblastic Tumors: Case Reports”. Voprosy onkologii 70, no. 2 (May 6, 2024): 384–389. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/2-24-Ten-Year.